RSV vaccine competition heats up as Pfizer’s shot for older adults gets FDA approval
June 01, 2023 at 11:46 AM EDT
Global market for RSV vaccine could reach $17 billion by 2033, analysts say.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|